MAPT and Alzheimer disease: Regardless of mechanism, our findings of potential amyloid-mediated associations between the NLR, tau pathology, and neurodegeneration may be supported by Ising et al. who demonstrated that activation of the NLRP3 inflammasome mediates Aβ-induced tau pathology in the AD mouse model [69].